EIKN · Eikon Therapeutics, Inc.
$10.75
-1.26 (-10.49%)
At close · Aug 20
Market Cap
$655.40M
Shares
54.17M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joshua Wolfe | Board of Directors | Resigned | 2026-08-03 |
| Leon Chen, Ph.D. | Board of Directors | Resigned | 2026-08-03 |
| Ma. Fatima D. Francisco | Class I director | Appointed | 2026-06-10 |
Key facts
CIK
1861123
CUSIP
282564103
13F (30d)
75 filings
73 filers
Visit website
Investor relations